Clinical Trial Update: A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports a study comparing blood levels and safety of tazemetostat in participants with advanced cancer and hepatic impairment versus t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Tazemetostat (tazemetostat)

Snippet

Sponsor: Epizyme, Inc. | Conditions: Hepatic Impairment, Advanced Malignant Solid Tumor | Phase 1 | Status: TERMINATED